Weikai Guo

409 total citations
18 papers, 277 citations indexed

About

Weikai Guo is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Weikai Guo has authored 18 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Weikai Guo's work include Protein Degradation and Inhibitors (5 papers), CAR-T cell therapy research (4 papers) and Synthesis and biological activity (3 papers). Weikai Guo is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), CAR-T cell therapy research (4 papers) and Synthesis and biological activity (3 papers). Weikai Guo collaborates with scholars based in China, France and Thailand. Weikai Guo's co-authors include Yihua Chen, Mingyao Liu, Zhengfang Yi, Haixiang Pei, Ting Shao, Hai Xiong, Wenbo Zhou, Xin Wang, Yuan He and Tingting Fan and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and Advanced Science.

In The Last Decade

Weikai Guo

17 papers receiving 277 citations

Peers

Countries citing papers authored by Weikai Guo

Since Specialization

Citations

This map shows the geographic impact of Weikai Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weikai Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weikai Guo more than expected).

Fields of papers citing papers by Weikai Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weikai Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weikai Guo. The network helps show where Weikai Guo may publish in the future.

Co-authorship network of co-authors of Weikai Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Weikai Guo. A scholar is included among the top collaborators of Weikai Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weikai Guo. Weikai Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma 2024 ·Molecular Cancer Therapeutics ·(unknown), Weikai Guo, Min Wu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mingyao Liu, Yihua Chen, Zhengfang Yi	0
2	Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA) 2024 ·Journal of Medicinal Chemistry ·Weikai Guo, (unknown), (unknown), Wenyu Li, Yanyang Zhao, Yuqing Yang, (unknown), (unknown), Zhou Liu, Yihua Chen, Qiming Li	14
3	Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy 2023 ·European Journal of Medicinal Chemistry ·Weikai Guo, (unknown), (unknown), Danyang Liu, (unknown), (unknown), Yihua Chen, Yanzhong Hu	15
4	Extracellular HSP90 promotes differentiation of lens epithelial cells to fiber cells by activating LRP1‐YAP‐PROX1 axis 2023 ·The FASEB Journal ·(unknown), Jingjing Yu, Weikang Huang, (unknown), Junmin Li, (unknown), (unknown), Mingli Wang, Kejia Li, Jun Zhang, Hui Li, Xiukun Cui, Jing Zhang, Mengyue Hu, (unknown), Weikai Guo, Fengyan Zhang, (unknown), Yanzhong Hu	2
5	Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer 2023 ·International Journal of Biological Sciences ·Min Wu, (unknown), (unknown), Lin Zhang, Chen Huang, (unknown), (unknown), (unknown), (unknown), (unknown), Cili Zhou, Mingyao Liu, Weikai Guo, Yihua Chen, Zhengfang Yi	5
6	A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia 2023 ·Biomedicine & Pharmacotherapy ·Zhang Li, Min Wu, Weikai Guo, Shuangshuang Zhu, Shen Li, (unknown), Yan Li, (unknown), (unknown), Chen Huang, Mingyao Liu, Shihong Peng, Yihua Chen, Zhengfang Yi	6
7	Biotin attenuates heat shock factor 4b transcriptional activity by lysine 444 biotinylation 2022 ·Biochemistry and Biophysics Reports ·(unknown), (unknown), (unknown), (unknown), Kejia Li, Mingli Wang, (unknown), (unknown), Hui Li, (unknown), Weikai Guo, Mengyue Hu, Jing Zhang, Zhengyan Yang, (unknown), (unknown), Jun Zhang, Xiukun Cui, Yanzhong Hu	1
8	An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo 2022 ·Cancer Letters ·(unknown), Weikai Guo, Min Wu, (unknown), (unknown), Pan Hu, (unknown), Lin Zhang, Qiansen Zhang, Peili Wang, Xin Wang, Guixue Wang, Huangan Wu, Cili Zhou, Yihua Chen, Mingyao Liu, Zhengfang Yi, Zhenliang Sun	16
9	Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective 2022 ·Medicinal Research Reviews ·Haixiang Pei, Weikai Guo, (unknown), Hai Xiong, Yihua Chen	30
10	Crosstalk between heat shock factor 1 and signal transducer and activator of transcription 3 mediated by interleukin‐8 autocrine signaling maintains the cancer stem cell phenotype in liver cancer 2022 ·Journal of Gastroenterology and Hepatology ·Zhengyan Yang, Wenjuan Wan, Pai Zhang, Shuangfeng Wang, Zhi Zhao, (unknown), (unknown), (unknown), (unknown), Ben Niu, Mingli Wang, Hui Li, Weikai Guo, Zhiguang Ren, Yanzhong Hu	2
11	B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Yuzhan Li, (unknown), (unknown), Weikai Guo, Bo Liu, Yihua Chen	18
12	Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth 2020 ·Journal of Medicinal Chemistry ·Weikai Guo, (unknown), Qiansen Zhang, (unknown), (unknown), (unknown), Peng He, (unknown), Shifen Xu, Xiufeng Pang, Mingyao Liu, Zhengfang Yi, Yihua Chen	25
13	Design, synthesis and evaluation of phenylthiazole and phenylthiophene pyrimidindiamine derivatives targeting the bacterial membrane 2020 ·European Journal of Medicinal Chemistry ·Tingting Fan, Weikai Guo, Ting Shao, Wenbo Zhou, Pan Hu, Mingyao Liu, Yihua Chen, Zhengfang Yi	28
14	[Expression of CDK6 and FOXM1 in peripheral T-cell lymphoma and their significance]. 2020 ·PubMed ·(unknown), (unknown), Pengcheng Bu, (unknown), (unknown), Yanfeng Xi, Weikai Guo	2
15	Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression 2020 ·Advanced Science ·(unknown), Yuan He, Xue Wang, (unknown), Meichun Hu, Weikai Guo, Yundong He, Tao Zhang, Li Lai, Zhenliang Sun, Zhengfang Yi, Mingyao Liu, Yihua Chen	42
16	Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin 2019 ·Journal of Medicinal Chemistry ·Yunqi Li, Yuan He, Ting Shao, Haixiang Pei, Weikai Guo, (unknown), Isabelle Krimm, (unknown), Peili Wang, Xin Wang, Mingyao Liu, Zhengfang Yi, Yihua Chen	29
17	Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents 2018 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Zhen Zhou, (unknown), Yuanjin Zhang, Haixiang Pei, Weikai Guo, Haigang Wu, Xin Wang, Mingyao Liu, Cai‐Guang Yang, Yihua Chen	21
18	Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents 2015 ·European Journal of Medicinal Chemistry ·Wenbo Zhou, (unknown), Yong Zhang, (unknown), Weikai Guo, (unknown), Zhengfang Yi, Mingyao Liu, Yihua Chen	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact